Company Shakeups

Pfizer Waging Battle Over Ranbaxy??

I was on a plane all day, headed to the BIO-LES seminar and didn’t get a chance to read the wire, so there is really no need to throw in my two cents at this point but the WSJ reported that Pfizer may be interested in topping the Daichii bid for Ranbaxy.  

Though Ranbaxy seems to be saying the Daichii is done, I wouldn’t completely count out Pfizer yet.  For more info, check out the pros:

- WSJ Health Blog

- Forbes

- Business Standard

 

Related articles

 

• Pfizer May Get Into Bidding For Ranbaxy, Generic Drug Maker [via Huffington Post]
• Japan set for $4.6bn pharma deal [via BBC]
• Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse [via Newswire]

 

 

Theoretically Related Posts

• June 11, 2008 -- Daiichi Sankyo Goes Generic with Ranbaxy Purchase (0)
• November 5, 2008 -- Another CB-1 Antagonist Bites the Dust: Pfizer Cancels CP-945,598 (0)
• October 23, 2008 -- No Rumors For You. Come Back. One Year (0)
• October 21, 2008 -- One Man’s Trash: Novartis Buys Nektar’s Pulmonary Division for $115M (0)
• October 20, 2008 -- Pfizer and UCB Announce Cyclofluidics: A Joint Venture (0)
• October 3, 2008 -- Swami Predicts ImClone’s Future (1)
• September 29, 2008 -- ImClone To Reveal Mystery Suitor? (0)
• September 10, 2008 -- ImClone Throws Down and Announces Additional Suitor (0)
• September 3, 2008 -- Pfizer Drops $225M Up-Front for Dimebon (0)
• June 19, 2008 -- Sanofi Gets Into Generics Game (0)

© 2008 Pharmababble.